P637 Incidence rate and clinical outcome of severe COVID-19 in Inflammatory Bowel Disease patients in a population-based setting

Por Rezazadeh Ardabili, A, Creemers, R H, Jonkers, D M A E, Romberg-Camps, M J L, Pierik, M J, van Bodegraven, A A
Publicado no J Crohns Colitis (2021)

Alternative procedure to shorten rectal barostat procedure for the assessment of rectal compliance and visceral perception: a feasibility study

Por Vanhoutvin, S. A. L. W., Troost, F. J., Kilkens, T. O. C., Lindsey, P. J., Jonkers, D. M. A. E., Venema, K., Masclee, A., Brummer, R-J. M.
Publicado em 2012

A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease

Por Gacesa, R., Vich Vila, A., Collij, V., Mujagic, Z., Kurilshikov, A., Voskuil, M.D., Festen, E.A.M., Wijmenga, C., Jonkers, D.M.A.E., Dijkstra, G., Fu, J., Zhernakova, A., Imhann, F., Weersma, R.K.
Publicado no Gut Microbes (2021)